trientine has been researched along with Fibrosarcoma in 3 studies
Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.
Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have reported that treatment with trientine, Cu-chelating agent, inhibits tumor growth in a murine transplantation model using fibrosarcoma and induces apoptosis in tumor cells in vivo and in vitro." | 7.75 | Trientine, a copper-chelating agent, induced apoptosis in murine fibrosarcoma cells by activation of the p38 MAPK pathway. ( ENDOH, D; HAYASHI, M; KADOWAKI, S; OKUI, T, 2009) |
| " We examined the effects of treatment with trientine, a copper-chelating agent, on tumor development in a murine xenograft model using fibrosarcoma-derived transplantable QRsp-11 cells and C57BL/6 mice and induction of apoptosis in tumor cells and endothelial cells in vivo and in vitro." | 7.74 | Trientine, a copper-chelating agent, induced apoptosis in murine fibrosarcoma cells in vivo and in vitro. ( Chiba, T; Endoh, D; Hayashi, M; Kon, Y; Nishiya, H; Okui, T, 2007) |
| "Combined effects of treatment with trientine, a copper-chelating agent, and X-irradiation on development of fibrosarcoma using a murine transplantation model in vivo and on cellular survival in vitro were examined." | 7.74 | Combined effects of treatment with trientine, a copper-chelating agent, and x-irradiation on tumor growth in transplantation model of a murine fibrosarcoma. ( Endoh, D; Hayashi, M; Hirai, R; Horiguchi, N; Ishihara, Y; Okui, T, 2007) |
| "We have reported that treatment with trientine, Cu-chelating agent, inhibits tumor growth in a murine transplantation model using fibrosarcoma and induces apoptosis in tumor cells in vivo and in vitro." | 3.75 | Trientine, a copper-chelating agent, induced apoptosis in murine fibrosarcoma cells by activation of the p38 MAPK pathway. ( ENDOH, D; HAYASHI, M; KADOWAKI, S; OKUI, T, 2009) |
| " We examined the effects of treatment with trientine, a copper-chelating agent, on tumor development in a murine xenograft model using fibrosarcoma-derived transplantable QRsp-11 cells and C57BL/6 mice and induction of apoptosis in tumor cells and endothelial cells in vivo and in vitro." | 3.74 | Trientine, a copper-chelating agent, induced apoptosis in murine fibrosarcoma cells in vivo and in vitro. ( Chiba, T; Endoh, D; Hayashi, M; Kon, Y; Nishiya, H; Okui, T, 2007) |
| "Combined effects of treatment with trientine, a copper-chelating agent, and X-irradiation on development of fibrosarcoma using a murine transplantation model in vivo and on cellular survival in vitro were examined." | 3.74 | Combined effects of treatment with trientine, a copper-chelating agent, and x-irradiation on tumor growth in transplantation model of a murine fibrosarcoma. ( Endoh, D; Hayashi, M; Hirai, R; Horiguchi, N; Ishihara, Y; Okui, T, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KADOWAKI, S | 1 |
| ENDOH, D | 3 |
| OKUI, T | 3 |
| HAYASHI, M | 3 |
| Nishiya, H | 1 |
| Chiba, T | 1 |
| Kon, Y | 1 |
| Hirai, R | 1 |
| Ishihara, Y | 1 |
| Horiguchi, N | 1 |
3 other studies available for trientine and Fibrosarcoma
| Article | Year |
|---|---|
Trientine, a copper-chelating agent, induced apoptosis in murine fibrosarcoma cells by activation of the p38 MAPK pathway.
Topics: Animals; Apoptosis; Cell Line, Tumor; Chelating Agents; Copper; Enzyme Activation; Fibrosarcoma; Imi | 2009 |
Trientine, a copper-chelating agent, induced apoptosis in murine fibrosarcoma cells in vivo and in vitro.
Topics: Animals; Apoptosis; Cattle; Cell Survival; Chelating Agents; Endothelial Cells; Fibrosarcoma; Flow C | 2007 |
Combined effects of treatment with trientine, a copper-chelating agent, and x-irradiation on tumor growth in transplantation model of a murine fibrosarcoma.
Topics: Animals; Antineoplastic Agents; Chelating Agents; Fibrosarcoma; Male; Mice; Mice, Inbred C57BL; Neop | 2007 |